Cargando…
New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma
The management of multiple myeloma has fundamentally changed over the years and imaging techniques able to match the therapeutic advances are now much needed. Although many patients now achieve complete response after first-line treatment, relapse is common. Therefore, it would be important to impro...
Autores principales: | Mesguich, Charles, Zanotti-Fregonara, Paolo, Hindié, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729776/ https://www.ncbi.nlm.nih.gov/pubmed/26877786 http://dx.doi.org/10.7150/thno.14400 |
Ejemplares similares
-
Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020) -
Prospective Comparison of 18-FDG PET/CT and Whole-Body MRI with Diffusion-Weighted Imaging in the Evaluation of Treatment Response of Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant
por: Mesguich, Charles, et al.
Publicado: (2021) -
Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial
por: Mesguich, Charles, et al.
Publicado: (2020) -
Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease
por: Champion, Christophe, et al.
Publicado: (2016) -
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
por: Hindié, Elif
Publicado: (2017)